Skip to main content
. 2020 Nov 9;11:537402. doi: 10.3389/fneur.2020.537402

Table 2.

Comparison of clinical efficacy in each group.

Variable NXAS (n = 30) Zopiclone (n = 30) Placebo (n = 30)
Rehabilitation, n 2 1 0
Markedly effective, n 10 11 0
Effective, n 11 12 9
Invalid, n 7 6 21
Effectiveness (%) 76.67 80.00 30.00
P-value <0.01